Grifols GRFS
NASDAQ GRFS
$8.62 -0.14 (-1.60%)
As of: Nov 11, 2026 · 10:06 AM EST

Grifols (GRFS) Operating Leases (2015 - 2025)

Updated

Analysis

Grifols (GRFS) Operating Leases (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Grifols 5.96 Bn 5.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.14 Bn
Dec 31, 2024 1.07 Bn
Dec 31, 2023 1.11 Bn
Dec 31, 2022 975.02 Mn
Dec 31, 2021 934.49 Mn
Dec 31, 2020 849.75 Mn
Dec 31, 2019 780.00 Mn
Mar 31, 2016 853.41 Mn
Dec 31, 2015 854.40 Mn
API Access

Grifols Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=GRFS&period=max&api_key=YOUR_API_KEY